Patient selection for TAVI in 2016: should we break through the low-risk barrier?

EuroIntervention 2016;12:Y46-Y50. DOI: 10.4244/EIJV12SYA11

Mohammad Abdelghani
Mohammad Abdelghani1, MD, MSc; Patrick W. Serruys2*, MD, PhD
1. Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 2. International Centre for Circulatory Health, NHLI, Imperial College London, London, United Kingdom

The earliest evidence supporting transcatheter aortic valve implantation (TAVI) was derived from its comparison with conservative therapy in inoperable patients and with surgical aortic valve replacement (SAVR) in extremely h

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Interventions for valvular diseaseTAVI
Read next article
Percutaneous repair of the tricuspid valve using a novel cinching device: acute and chronic experience in a preclinical large animal model

Latest news